Clinical Trials for Sellas Life Sciences Group

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Sellas Life Sciences Group

Clinical Trials (2)

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies

PHASE1/PHASE2Recruiting

160 participants

Started: May 10, 2021 · Completed: Dec 31, 2025

1 condition1 sponsor21 locations

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

PHASE3Active, not recruiting

127 participants

Started: Feb 8, 2021 · Completed: Dec 31, 2026

1 condition2 sponsors73 locations